Pipelinepharma Logo
Pipelinepharma Logo

CTD Dossier Marketplace

Direct connection with CTD dossier (IP) owners and manufacturers

Marketing Authorizations Database

Search across marketing authorization registers

Active Pharmaceutical Ingredient Database

Search active pharmaceutical ingredient records

Sign in Get started

Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Terazosin manufacturers

Filters

Filters

Filters , active

Country of origin : India
None products found

terazosin

Capsules 1 mg, 2 mg, 5 mg & 10 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA
Manufacturer #33853

Established in 2017, this pharmaceutical manufacturer specializes in developing and producing affordable, high-quality complex generics. As a CTD dossier owner and manufacturer, it holds multiple GMP certifications, including approvals from the US FDA, DEA, WHO GMP, and ISO, ensuring compliance with stringent international quality standards. The company operates three manufacturing facilities, including a US FDA-approved formulation plant and an API & intermediates manufacturing plant, with 14 manufacturing lines dedicated to emerging markets. Its diverse product portfolio encompasses tablets, capsules, liquids, dry syrups, oral rehydration solutions, active pharmaceutical ingredients, and critical care injectables, such as antibiotics, antifungals, and blood line products. With a presence in 49 countries and over 270 commercial products, the manufacturer is committed to enhancing global healthcare accessibility

terazosin

Tablets 1 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #10170
A pharmaceutical manufacturer providing export-oriented development and commercial supply of pharmaceutical products across a complete range of finished dosage forms, including tablets, capsules, softgels, injectables, ointments, dry syrups, and sachet presentations. The organisation positions itself as a licensing-and-supply partner with integrated manufacturing expertise and a growing international portfolio, and it reports holding multiple regulatory approvals from major global authorities (including MHRA, TGA, ANVISA and GCC regulators) alongside WHO-GMP compliance for its manufacturing operations, supporting consistent quality and reliability of pharmaceutical products for overseas partners.

terazosin

Tablets 1mg, 2mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19412
This pharmaceutical group is experiencing rapid growth, increasing its turnover from Rs. 1.5 crores in 2006 to Rs. 12 crores by 2009-2010 and aiming for Rs. 50 crores by 2015. While specific product details are not provided, the company operates across diverse therapeutic areas with a focus on both prescription medications and over-the-counter drugs. They highlight their management team's vision and dynamism, suggesting strong leadership driving their expansion within India.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Terazosin is a medication used to relieve the symptoms of enlarged prostate and hypertension. Suppliers of terazosin market it in the form of 1mg, 2mg, 5mg, and 10mg oral tablets. The drug was first introduced into the market in 1985 under the trade name Hytrin by developer and earliest manufacturer of terazosin – Abbot Pharmaceuticals. Abbot continues to hold the largest share of the terazosin market, however, other manufacturers and suppliers have since introduced their formulations of the medication. Other major pharmaceutical manufacturers of terazosin currently include Boston Scientific, Vascular Medical, and MicroPort, whereas major suppliers are companies Mylan, Teva and Sandoz. Terazosin suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified terazosin manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.